Page last updated: 2024-10-16

carbamates and Myositis, Inclusion Body

carbamates has been researched along with Myositis, Inclusion Body in 1 studies

Myositis, Inclusion Body: Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuwano, T1
Akuta, N1
Suzuki, F1
Fujiyama, S1
Kawamura, Y1
Sezaki, H1
Hosaka, T1
Saitoh, S1
Kobayashi, M2
Suzuki, Y1
Arase, Y1
Ikeda, K1
Kumada, H1

Other Studies

1 other study available for carbamates and Myositis, Inclusion Body

ArticleYear
A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis.
    Internal medicine (Tokyo, Japan), 2018, Sep-01, Volume: 57, Issue:17

    Topics: Aged; Anilides; Antiviral Agents; Carbamates; Cryoglobulinemia; Cyclopropanes; Female; Hepatitis C,

2018